Drugs / PROSTAC-V/TRICOM
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00450619 | Feb 2007 → Nov 2012 | prostate cancer | National Cancer Institute (NCI) | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PROSTAC-V/TRICOM | “PROSTAC-V/TRICOM (vaccinia) 2 x 10\^8 plaque forming unit (pfu) subcutaneously on day 1.” NCT00450619 ↗ |
| Route | Subcutaneous | “2 x 10\^8 plaque forming unit (pfu) subcutaneously on day 1” NCT00450619 ↗ |